Identity
- Trade Name
- Vive Mobility FDA UDI
- Generic Name
- Attendant-only-propelled wheelchair, non-bariatric FDA UDI
- Device Name
- Active Wheelchair (Blue) FDA UDI
- Model / Reference
- MOB1101BLU FDA UDI
- Description
- Active Wheelchair (Blue) FDA UDI
Identifiers
- Primary DI / UDI-DI
- 00810113576879 FDA UDI
- FDA Product Code
- IOR FDA UDI
- GMDN Term
- Attendant-only-propelled wheelchair, non-bariatric FDA UDI
Classification
- Device Class
- Class I FDA UDI
- Regulation Number
- 890.3850 FDA UDI
- Commercial Distribution
- In Commercial Distribution FDA UDI
Clinical & Handling
Sterile
No
FDA UDI
Single Use
No
FDA UDI
Implantable
No
FDA UDI
Contains Latex
No
FDA UDI
Prescription Use
No
FDA UDI
Over-the-Counter
Yes
FDA UDI
Convenience Kit
No
FDA UDI
Combination Product
No
FDA UDI
HCT/P
No
FDA UDI
Premarket Exempt
Yes
FDA UDI
Lot / Batch Number
No
FDA UDI
Serial Number
No
FDA UDI
Expiration Date
No
FDA UDI
Manufacturing Date
No
FDA UDI
Category: Attendant-only-propelled wheelchair, non-bariatric
Vive Mobility by Vive Health Llc — Class I — FDA UDI — listed in FDA GUDID — regulatory data on deviCERTS
Similar devices
Also classified as Attendant-only-propelled wheelchair, non-bariatric.
- Drive — Drive Devilbiss Healthcare · Class I
- MEDLINE — MEDLINE INDUSTRIES, INC. · Class I
- Drive — Drive Devilbiss Healthcare · Class I
- Drive — Drive Devilbiss Healthcare · Class I
- drive — Drive Devilbiss Healthcare · Class I
- Convaid — Convaid Products LLC · Class I
- Spencer — SPENCER ITALIA SRL · Class I
- Drive — Drive Devilbiss Healthcare · Class I
Authorization Coverage (1 country)
Regulatory Authorizations
United States Pending data
FDA UDI
| Source | Region | Type | Cert / Approval No. | Class | Status |
|---|---|---|---|---|---|
| FDA UDI | United States | FDA UDI | Registered in GUDID | Class I | Pending data |
Is this your device? Claim it to add documentation and request validation.
Manufacturer
- Manufacturer
- Vive Health Llc
Sources (1)
- FDA UDI c4b7d596-9b5c-4b9c-8309-d124b96b01b6 33 fields · synced Jun 8, 2026